ModelEdge

MyMD Pharmaceuticals Inc.
MYMD
Filing Type8-K
Filing Date9/1/2025
Updated9/2/25, 7:29 AM

Filing

8-K
Earnings Release

Exhibits

8-KMaterial Contracts, End of Material Contract, Unregistered Sales of Equity Securities, Material Modifications to Rights of Security Holders, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Reg. FD
EX-3.1EX-3.1
EX-3.2EX-3.2
EX-3.3EX-3.3
EX-3.4EX-3.4
EX-4.1EX-4.1
EX-10.1EX-10.1
EX-10.2EX-10.2
EX-10.3EX-10.3
EX-99.1Material Contracts, End of Material Contract, Unregistered Sales of Equity Securities, Material Modifications to Rights of Security Holders, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Reg. FD
EX-99.2Material Contracts, End of Material Contract, Unregistered Sales of Equity Securities, Material Modifications to Rights of Security Holders, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Reg. FD
GRAPHICGraphic